Journals / Journal of Clinical Research in Pediatric Endocrinology / 2021 / Cilt: 13 - Sayı: 2

Initial Basal and Bolus Rates and Basal Rate Variability During Pump Treatment in Children and Adolescents

Pages
198–203
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Circadian distribution of BI differed markedly amongthe five age groups.Conclusion: At the initiation of insulin pump therapy, circadian profiles by age group should be taken into account in pediatric patientsto optimize basal rate faster and more easily.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Pump-treated children with type 1 diabetes (T1DM) have widely differing basal insulin (BI) infusion profiles for specificperiods of the day.
📊
Key Findings & Data:In adolescents and young adults, a decreased insulin sensitivity is seen, particularly in the early morning (dawnphenomenon) and to a lesser extent, in the late afternoon (dusk phenomenon).
💡
Conclusion & Impact:Circadian distribution of BI differed markedly amongthe five age groups.Conclusion: At the initiation of insulin pump therapy, circadian profiles by age group should be taken into account in pediatric patientsto optimize basal rate faster and more easily.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Pump-treated children with type 1 diabetes (T1DM) have widely differing basal insulin (BI) infusion profiles for specificperiods of the day. The pattern of BI requirements depends on the timing and magnitude of cortisol and growth hormone secretionwithin each age group. In adolescents and young adults, a decreased insulin sensitivity is seen, particularly in the early morning (dawnphenomenon) and to a lesser extent, in the late afternoon (dusk phenomenon). Different approaches exist for the inititation of basalrates. However, there is a lack of evidence-based recommendation, especially in young children. Usually the basal rates are set equallythroughout day and night or the day is divided into tertiles. The aim of this study was to analyze the change of the initial, equallydistributed, BI rates over the first year of standard insulin pump therapy.Methods: A total of 154 patients with T1DM, aged between 0 and 18 years, (n=5). Distribution of hourly basal rates at theinitiation of the pump and at the end of first year were evaluated.Results: Median (range) age and diabetes duration was 14.46 (1.91-26.15) and 7.89 (1.16-17.15) years, respectively. Forty-four percentwere male, 56% were female. Mean total insulin dose/kg in the whole cohort at the initiation and after one year of pump therapy was0.86±0.23 U/kg and 0.78±0.19 U/kg, respectively and differed significantly between each age group (p<0.001; p<0.001). Mean dailybasal rate/kg showed significant differences between the five groups (p<0.001). Circadian distribution of BI differed markedly amongthe five age groups.Conclusion: At the initiation of insulin pump therapy, circadian profiles by age group should be taken into account in pediatric patientsto optimize basal rate faster and more easily.

🔖

Cite This Article

DEMİR, G., ALTINOK, Y. A., ÖZEN, S., DARCAN, Ş., GÖKŞEN, D. (2021). Initial Basal and Bolus Rates and Basal Rate Variability During Pump Treatment in Children and Adolescents. Journal of Clinical Research in Pediatric Endocrinology, Cilt: 13 - Sayı: 2, 198–203. https://ajindex.com/articles/347736

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. Insulin Pump Risks and Benefits: A Clinical Appraisal of Pump Safety Standards, Adverse Event Reporting, and Research Needs A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetes Care 2015;38:716-722
  2. Rabbone I, Bobbio A, Berger K, Trada M, Sacchetti C, Cerutti F. Agerelated differences in metabolic response to continuous subcutaneous insulin infusion in pre-pubertaland pubertal children with Type 1 diabetes mellitus. J Endocrinol Invest 2007;30:477-483
  3. Ahern JAH, Boland EA, Doane R, Ahern JJ, Rose P, Vincent M, Tamborlane WV. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Pediatric Diabetes 2002:3:10-15
  4. Schiel R, Burgard D, Perenthaler T, Stein G, Kramer G, Steveling A. Use and Effectiveness of Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Daily Insulin Injection Therapy (MIT) in Children, Adolescents and Young Adults with Type 1 Diabetes Mellitus. Exp Clin Endocrinol Diabetes 2016;124:99-104
  5. Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV. A randomized prospective trial comparing the efficacy efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004;27:1554-1558
  6. Phillip M, Battelino T, Rodriguez H, Danne T, Kaufman F; European Society for Paediatric Endocrinology; Lawson Wilkins Pediatric Endocrine Society; International Society for Pediatric and Adolescent Diabetes; American Diabetes Association; European Association for the Study of Diabetes. Use of insulin pump therapy in the pediatric agegroup: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2007;30:1653-1662
  7. Grunberger G, Abelseth JM, Bailey TS, Bode BW, Handelsman Y, Hellman R, Jovanovič L, Lane WS, Raskin P, Tamborlane WV, Rothermel C. Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force. Endocr Pract 2014;20:463-489
  8. Bachran R, Beyer P, Klinkert C, Heidtmann B, Rosenbauer J, Holl RW;